In this study, we confirmed that ACE2 cross-reactive antibodies were increased in the sera of some patients with COVID-19 and found a positive association between the amount of antibody binding to ACE2 and S1-RBD in sera from patients with COVID-19. Here, ACE2 is linked to COVID-19.